Semaglutide (Rybelsus®) Clinical Trials
5 recruitingDrug
Phase 32Phase 41Early Phase 11Phase 21
Showing 1–5 of 5 trials
Recruiting
Phase 2
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Cardiovascular Disease PreventionSmoking, CigaretteHIV+1 more
Vanderbilt University Medical Center200 enrolled1 locationNCT07221214
Recruiting
Phase 4
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Diabetes Mellitus, Type 2Obesity, OverweightPsoriasis (PsO)
Hospital Universitario Dr. Jose E. Gonzalez62 enrolled1 locationNCT07401992
Recruiting
Phase 3
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Acute Myocardial Infarction With ST Elevation
Instituto Mexicano del Seguro Social44 enrolled1 locationNCT07295223
Recruiting
Phase 3
Epicardial Cardiac Fat-CT (EPIC-CT)
Epicardial fatSTEMI - ST Elevation Myocardial Infarction
Instituto Mexicano del Seguro Social136 enrolled1 locationNCT07297589
Recruiting
Early Phase 1
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Type 1 Diabetes
Vanderbilt University Medical Center24 enrolled1 locationNCT06338553